Sign in

CIK 0001637715 · <br>Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472309515
Phone
(720) 307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 35 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-08-31 GREY MICHAEL G Executive Chairman Option exercise +50,000 $1.97 $99K 50,000
2022-08-31 GREY MICHAEL G Executive Chairman Option exercise · Stock option (right to buy) −50,000 67,406
2022-08-31 Cruse Michael Chief Operating Officer Purchase +3,212 $3.21 $10K 6,197
2022-08-30 Cruse Michael Chief Operating Officer Purchase +975 $3.16 $3K 31,758
2022-08-30 Cruse Michael Chief Operating Officer Purchase +1,845 $3.19 $6K 2,985
2022-08-29 Cruse Michael Chief Operating Officer Purchase +83 $3.24 $269 30,783
2022-08-29 Cruse Michael Chief Operating Officer Purchase +1,140 $3.24 $4K 1,140
2022-08-12 Dorenbaum Alejandro Chief Medical Officer Gift −22,348 30,000
2022-08-02 Blunt Roshawn A. Director Grant or award · Stock Option (right to buy) +35,000 35,000
2022-06-01 Mathers Edward T Director Grant or award · Stock Option (right to buy) +17,500 17,500
2022-06-01 GREY MICHAEL G Executive Chairman Grant or award · Stock Option (right to buy) +17,500 17,500
2022-06-01 Hoelscher Paul W. Director Grant or award · Stock Option (right to buy) +6,376 6,376
2022-06-01 Dube Eric M Director Grant or award · Stock Option (right to buy) +17,500 17,500
2022-06-01 Muralidhar Bali Director Grant or award · Stock Option (right to buy) +17,500 17,500

Page 8 of 8 · 154 trades